JNCI Journal of the National Cancer Institute

REVIEWS

AM Goldstein and MA Tucker

Screening for CDKN2A mutations in hereditary melanoma
J. Natl. Cancer Inst. 1997 89: 676; doi:10.1093/jnci/89.10.676 [PDF]  

Y Hasui and Y Osada

Urokinase-type plasminogen activator and its receptor in bladder cancer
J. Natl. Cancer Inst. 1997 89: 678; doi:10.1093/jnci/89.10.678 [PDF]  

NEWS

NJ Nelson

Cancer risk high, but lower than expected with breast cancer genes
J. Natl. Cancer Inst. 1997 89: 680; doi:10.1093/jnci/89.10.680 [PDF]  

C McNeil

Potential drug DHEA hits snags on way to clinic
J. Natl. Cancer Inst. 1997 89: 681.  

D Holzman

Green tea, mistletoe, and more: Canadians test alternative cancer therapies
J. Natl. Cancer Inst. 1997 89: 683.  

P Eastman

IOM study will probe NIH-supported cancer research affecting minorities
J. Natl. Cancer Inst. 1997 89: 685.  

K Hardy

Clinical trials need more ethnic balance
J. Natl. Cancer Inst. 1997 89: 686.  

ARTICLES

JW Aquilina, JJ Lipsky, and DG Bostwick

Androgen deprivation as a strategy for prostate cancer chemoprevention
J. Natl. Cancer Inst. 1997 89: 689; doi:10.1093/jnci/89.10.689 [PDF]  

A Platz, J Hansson, E Mansson-Brahme, B Lagerlof, S Linder, E Lundqvist, P Sevigny, M Inganas, and U Ringborg

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
J. Natl. Cancer Inst. 1997 89: 697; doi:10.1093/jnci/89.10.697 [Abstract] [PDF]  

SM Miller, KK Siejak, CM Schroeder, C Lerman, E Hernandez, and CW Helm

Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy
J. Natl. Cancer Inst. 1997 89: 703; doi:10.1093/jnci/89.10.703 [Abstract] [PDF]  

MA Hudson and LM McReynolds

Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines
J. Natl. Cancer Inst. 1997 89: 709; doi:10.1093/jnci/89.10.709 [Abstract] [PDF]  

JJ Michnovicz, H Adlercreutz, and HL Bradlow

Changes in levels of urinary estrogen metabolites after oral indole-3- carbinol treatment in humans
J. Natl. Cancer Inst. 1997 89: 718; doi:10.1093/jnci/89.10.718 [Abstract] [PDF]  

H Kinoshita, O Ogawa, Y Kakehi, M Mishina, K Mitsumori, N Itoh, H Yamada, T Terachi, and O Yoshida

Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer
J. Natl. Cancer Inst. 1997 89: 724; doi:10.1093/jnci/89.10.724 [Abstract] [PDF]  

CORRESPONDENCE

F Eisinger, CJ Reynier, F Chabal, C Luquet, JP Moatti, and H Sobol

Acceptable strategies for dealing with hereditary breast/ovarian cancer risk
J. Natl. Cancer Inst. 1997 89: 731; doi:10.1093/jnci/89.10.731 [PDF]  

C La Vecchia, E Negri, F Levi, and A Decarli

Age, cohort-of-birth, and period-of-death trends in breast cancer mortality in Europe
J. Natl. Cancer Inst. 1997 89: 732; doi:10.1093/jnci/89.10.732 [PDF]  

M Paolini, GL Biagi, and G Cantelli-Forti

A hidden paradox in carcinogenesis bioassays
J. Natl. Cancer Inst. 1997 89: 736; doi:10.1093/jnci/89.10.736 [PDF]  

RI Freudenthal and DP Anderson

Monitoring of aromatic amine exposures in workers at a chemical plant with known bladder cancer excess
J. Natl. Cancer Inst. 1997 89: 734.  

ER Stephens

Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess
J. Natl. Cancer Inst. 1997 89: 734.  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.